Current approaches and challenges in monitoring treatment responses in breast cancer.
about
Optical imaging for breast cancer prescreening.Ultrasound imaging of breast tumor perfusion and neovascular morphology.RAS pathway biomarkers for breast cancer prognosis.Coordinate hyperactivation of Notch1 and Ras/MAPK pathways correlates with poor patient survival: novel therapeutic strategy for aggressive breast cancers.AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.Computer-aided breast MR image feature analysis for prediction of tumor response to chemotherapyTesting chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids.Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.SIAH and EGFR, Two RAS Pathway Biomarkers, are Highly Prognostic in Locally Advanced and Metastatic Breast CancerSpecial issue on current challenges and future directions in monitoring responses after treatment of primary cancerCirculating cell-free DNA-based epigenetic assay can detect early breast cancer.Monitoring Neoadjuvant Chemotherapy for Breast Cancer by Using Three-dimensional Subharmonic Aided Pressure Estimation and Imaging with US Contrast Agents: Preliminary Experience.The efficacy of interventions to improve psychosocial outcomes following surgical treatment for breast cancer: a systematic review and meta-analysis.'Dropped from the system': the experiences and challenges of long-term breast cancer survivors.FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.Treatment of Male Breast Cancer by Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade and Response Prediction Using Novel Optical Tomography Imaging: A Case Report.Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy.Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy.Tumor tissue katanin P60 expression correlates with lymph node metastasis and worse prognosis in patients with breast cancer: A cohort study.Appearance Constrained Semi-Automatic Segmentation from DCE-MRI is Reproducible and Feasible for Breast Cancer Radiomics: A Feasibility Study.Investigation of apoptotic events at molecular level induced by SERS guided targeted theranostic nanoprobe.Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancerRoutine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer-Where is the evidence?
P2860
Q26801115-891777A2-C3FB-473F-8903-1ECC980E2742Q30375552-DACEE9B9-F1B9-4069-8012-C7DB738A11E1Q33757299-F2345BC3-69EB-418E-BB16-408E3EE78F8CQ34646291-72C3F8A0-F02C-48A0-BE30-596ABAB57184Q35432936-571743D6-1FC9-4B33-8B9F-496DDF7E2F16Q36198800-63EAB353-3152-4A93-8F54-B8FBE3764013Q36866538-2757A917-740D-43D5-8576-2831296D76D0Q37154212-82E9F064-9013-496C-94E0-A1EA8AAD5762Q37309686-0D27C877-92B5-47F8-88EA-A584D3A69C90Q37435175-82A9345D-0DA3-4F4A-9DF4-24B371B916DFQ37517411-28ECE5B7-734B-41D7-A323-121DAE33F955Q38807259-F90DED2B-327F-485F-801B-195971A3D770Q38849717-12C9F2CB-7548-4E7D-A1BA-EBCBC36C3097Q39093100-558A2B18-4F00-4368-A452-3E6BD8545A6BQ39612494-F63447CA-75B7-4726-B2D9-F394AA756290Q41698953-46D1CB12-3672-42A0-AC70-FBADF8034694Q42663270-FE3D7D1B-FF42-4E0D-897B-53B766F5BDA6Q45074157-5CC49672-7ED1-4812-BDD9-B0C92B5FE27AQ46088835-092E1C80-14FB-4C29-BB35-DE3202DA4755Q50157910-5EDD4DC6-398B-4271-A6FD-A50A89FE4B5AQ52647855-7EE4323A-1EDC-4D0C-AE74-35194CDD38BDQ52867979-B102FE62-ADE8-4582-A4FF-6131C1D98F51Q57295430-E7B2901C-EA7B-4269-B3A8-786489F47BF3Q58733117-045558BB-5FF0-4388-9A8F-A88877C690CD
P2860
Current approaches and challenges in monitoring treatment responses in breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Current approaches and challenges in monitoring treatment responses in breast cancer.
@ast
Current approaches and challenges in monitoring treatment responses in breast cancer.
@en
Current approaches and challenges in monitoring treatment responses in breast cancer.
@nl
type
label
Current approaches and challenges in monitoring treatment responses in breast cancer.
@ast
Current approaches and challenges in monitoring treatment responses in breast cancer.
@en
Current approaches and challenges in monitoring treatment responses in breast cancer.
@nl
prefLabel
Current approaches and challenges in monitoring treatment responses in breast cancer.
@ast
Current approaches and challenges in monitoring treatment responses in breast cancer.
@en
Current approaches and challenges in monitoring treatment responses in breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Current approaches and challenges in monitoring treatment responses in breast cancer.
@en
P2093
Aaron D Kirkpatrick
Alexander Stojadinovic
Aviram Nissan
Chris Gallagher
Erika J Schneble
Frederick L Flynt
George E Peoples
Leonard Henry
Lindsey J Graham
Matthew P Shupe
P2860
P356
10.7150/JCA.7047
P577
2014-01-05T00:00:00Z